ABK Ambac Financial Grp. Common Stock

The Bedford Report is pleased to announce that its latest Market Update analyzing recent news and events on Pfizer, Inc. (NYSE: PFE), Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA), Ambac Financial Group, Inc. (NYSE: ABK) and Toyota Motor Corp. (NYSE: TM) has been released.

In this issue of The Bedford Report we address the likelihood of Ambac filing for bankruptcy in the near future. We also review news of Teva gaining regulatory approval in Canada to market a generic version of Pfizer's cholesterol drug Lipitor, and explain what it means for both Teva and Pfizer. Furthermore, we forecast Toyota's earnings potential for the remainder of the year. There is much more analysis regarding these companies and many more available at www.bedfordreport.com.

Our updated analyst reports on Pfizer, Teva, Ambac and Toyota include:

-- An unbiased view and rating of the company -- Recent key developments -- Solid analyst summary -- who's saying what and why? -- In-depth industry analysis and outlook -- Major upcoming events to watch out for

Take the few minutes to register with us at www.BedfordReport.com and get access to numerous company reports and industry newsletters and stay abreast of market highlights so you can make the best investment decisions at the right time. Like you, we realize that timing is everything and so we only put out updates and analysis when the markets are ripe for immediate action.

BedfordReport.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.

Please view the full disclaimer: http://www.BedfordReport.com/disclaimer.php.

Contact: The Bedford Report Email Contact